(Q38045766)

27 August 2017

title

Overexpression of p53 protein in human tumors (English)

1 reference

27 August 2017

2

Atsushi Kurabayashi

1 reference

27 August 2017

Keiji Inoue

1

1 reference

27 August 2017

Taro Shuin

series ordinal

3

1 reference

27 August 2017

Yuji Ohtsuki

series ordinal

4

1 reference

27 August 2017

Mutsuo Furihata

series ordinal

5

1 reference

27 August 2017

publication date

1 June 2012

1 reference

Medical Molecular Morphology

27 August 2017

published in

1 reference

27 August 2017

volume

45

1 reference

27 August 2017

issue

3

1 reference

27 August 2017

page(s)

115-123

1 reference

https://scigraph.springernature.com/pub.10.1007/s00795-012-0575-6

27 August 2017

exact match

0 references

cites work

The IARC TP53 database: new online mutation analysis and recommendations to users

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

p53: oncogene or anti-oncogene?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Participation of p53 cellular tumour antigen in transformation of normal embryonic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Clonal analysis of human colorectal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Genetic alterations during colorectal-tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Loss of heterozygosity on chromosomes 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Mutations in the p53 gene occur in diverse human tumour types

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

The p53 proto-oncogene can act as a suppressor of transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Localization of gene for human p53 tumour antigen to band 17p13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17p13)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

p53 mutations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

TP53 tumor suppressor gene: a model for investigating human mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

The p53 tumour suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Rescuing the function of mutant p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Presence of a potent transcription activating sequence in the p53 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

p53 protein variants: structural and functional similarities with p63 and p73 isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

p53 isoforms can regulate p53 transcriptional activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

p53 isoforms - a conspiracy to kidnap p53 tumor suppressor activity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

T antigen is bound to a host protein in SY40-transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Association of human papillomavirus types 16 and 18 E6 proteins with p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Arginine methylation regulates the p53 response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

SIRT1 regulates apoptosis and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

p53 transformation-related protein: detection by monoclonal antibody in mouse and human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Evidence for free and metabolically stable p53 protein in nuclear subfractions of simian virus 40-transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Intranuclear distribution of SV40 large T-antigen and transformation-related protein p53 in abortively infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Imino-tetrahydro-benzothiazole derivatives as p53 inhibitors: discovery of a highly potent in vivo inhibitor and its action mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Transcriptional regulation by p53: one protein, many possibilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Mdm2 and Mdm4 loss regulates distinct p53 activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Structural details on mdm2-p53 interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Stress signals utilize multiple pathways to stabilize p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Post-translational modifications and activation of p53 by genotoxic stresses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Regulation of p53 function and stability by phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

21 January 2018

Modes of p53 regulation

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Acetylation of the p53 DNA-binding domain regulates apoptosis induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Acetylation is indispensable for p53 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

SnapShot: p53 posttranslational modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Modifications of p53: competing for the lysines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

How p53 binds DNA as a tetramer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

DNA damage: a trigger of innate immunity but a requirement for adaptive immune homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Abelson murine leukemia virus-transformed cells that lack p53 protein synthesis express aberrant p53 mRNA species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Transcriptional activation by p53 correlates with suppression of growth but not transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Reconstitution of p53 expression in a nonproducer Ab-MuLV-transformed cell line by transfection of a functional p53 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Gain of function mutations in p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

p63 and p73 in human cancer: defining the network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Transcription regulation by mutant p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Transcriptional activities of mutant p53: when mutations are more than a loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Mutant p53: an oncogenic transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Gain of function of mutant p53: the mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

The clonal evolution of tumor cell populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

A genetic model for colorectal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Changes in bronchial epithelium in relation to cigarette smoking, 1955-1960 vs. 1970-1977

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Prognostic significance of serine 392 phosphorylation in overexpressed p53 protein in human esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Prognostic significance of p53 gene mutations and protein overexpression in localized gastrointestinal stromal tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

A detailed study of loss of heterozygosity on chromosome 17 in tumours from Li – Fraumeni patients carrying a mutation to the TP53 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Latent and active p53 are identical in conformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Increased expression of mutant forms of p53 oncogene in primary lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Human p53 gene localized to short arm of chromosome 17

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00795-012-0575-6

Wild type human p53 is antiproliferative in SV40-transformed hamster cells.

21 January 2018

1 reference

12 December 2020

The aberrant p53 protein (review).

1 reference

12 December 2020

Both germ line and somatic genetics of the p53 pathway affect ovarian cancer incidence and survival

1 reference

12 December 2020

High-risk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder

1 reference

12 December 2020

Use of the two-hybrid system to identify the domain of p53 involved in oligomerization

1 reference

12 December 2020

p53 and human cancer: the first ten thousand mutations.

1 reference

12 December 2020

Complex formation between the lymphotropic papovavirus large tumor antigen and the tumor suppressor protein p53.

1 reference

12 December 2020

Monoclonal antibodies against simian virus 40 T antigens: evidence for distinct sublcasses of large T antigen and for similarities among nonviral T antigens

1 reference

12 December 2020

p53 mutation arising in Arg72 allele in the tumorigenesis and development of carcinoma of the urinary tract.

1 reference

12 December 2020

Allele loss on short arm of chromosome 17 in breast cancers

1 reference

12 December 2020

Radioimmunoassay of the cellular protein p53 in mouse and human cell lines.

1 reference

12 December 2020

p73 function is inhibited by tumor-derived p53 mutants in mammalian cells.

1 reference

12 December 2020

Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells

1 reference

12 December 2020

TP53 DNA contact mutations are selectively associated with allelic loss and have a strong clinical impact in head and neck cancer

1 reference

12 December 2020

Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies

1 reference

12 December 2020

When mutants gain new powers: news from the mutant p53 field.

1 reference

12 December 2020

Overexpression of MDM2 and p53 protein is infrequently but significantly associated with progression of human prostatic adenocarcinoma.

1 reference

12 December 2020

Alterations in tumor development in vivo mediated by expression of wild type or mutant p53 proteins.

1 reference

12 December 2020

Phosphorylation state of tumor-suppressor gene p53 product overexpressed in skin tumors.

1 reference

12 December 2020

Massively regulated genes: the example of TP53.

1 reference

12 December 2020

The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites

1 reference

12 December 2020

Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form

1 reference

12 December 2020

Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation

1 reference

12 December 2020

Subcellular distribution of the p53 protein during the cell cycle of Balb/c 3T3 cells

1 reference

12 December 2020

Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome

1 reference

12 December 2020

A C-terminal alpha-helix plus basic region motif is the major structural determinant of p53 tetramerization

1 reference

12 December 2020

Sequencing analysis of RNA and DNA of exons 1 through 11 shows p53 gene alterations to be present in almost 100% of head and neck squamous cell cancers

1 reference

12 December 2020

Structural aspects of the p53 protein in relation to gene evolution

1 reference

12 December 2020

P53 transformation-related protein accumulates in the nucleus of transformed fibroblasts in association with the chromatin and is found in the cytoplasm of non-transformed fibroblasts

1 reference

12 December 2020

Clonal genomic alterations in glioma malignancy stages.

1 reference

12 December 2020

Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation

1 reference

12 December 2020

Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma

1 reference

12 December 2020

Widespread p53 overexpression in human malignant tumors. An immunohistochemical study using methacarn-fixed, embedded tissue

1 reference

12 December 2020

10.1007/S00795-012-0575-6

Identifiers

DOI

1 reference

27 August 2017

1 reference